CB1 antagonist 1
Code | Size | Price |
---|
TAR-T10510-5mg | 5mg | £1,171.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T10510-50mg | 50mg | £2,303.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T10510-100mg | 100mg | £3,042.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
CB1 antagonist 1 is a CB1 receptor antagonist, used in the research of obesity and metabolic syndrome, neuroinflammatory disorders, cognitive disorders, and gastrointestinal disorders, psychosis, and cardiovascular.
CAS:
890037-68-0
Formula:
C26H22Cl2N4
Molecular Weight:
461.39
Pathway:
GPCR/G Protein
Purity:
0.98
SMILES:
CC(N1CCN(C(C1)c1ccc(Cl)cc1)c1ccc(cc1Cl)C#N)c1ccc(cc1)C#N
Target:
Cannabinoid Receptor
References
1. Gilbert, Eric J, et al. SUBSTITUTED PIPERAZINES AS CB1 ANTAGONISTS. WO 2006060461 A1.